Market Cap (In KRW)
834.17 Billion
Revenue (In KRW)
1815.1 Billion
Net Income (In KRW)
152.66 Billion
Avg. Volume
270.48 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15050.0-28100.0
- PE
- -
- EPS
- -
- Beta Value
- 1.198
- ISIN
- KR7003090008
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Yeong-Hwan Yoon
- Employee Count
- -
- Website
- https://www.daewoongholdings.com
- Ipo Date
- 2000-01-04
- Details
- Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.
More Stocks
-
ARIC
-
WTE
-
CENLUBCenlub Industries Limited
CENLUB
-
YGG
-
TRIITrio Resources, Inc.
TRII
-
EVGN
-
EHL
-
PRKRParkerVision, Inc.
PRKR